DURABOLIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Durabolin, and when can generic versions of Durabolin launch?
Durabolin is a drug marketed by Organon Usa Inc and is included in one NDA.
The generic ingredient in DURABOLIN is nandrolone phenpropionate. There are fifteen drug master file entries for this compound. Additional details are available on the nandrolone phenpropionate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DURABOLIN?
- What are the global sales for DURABOLIN?
- What is Average Wholesale Price for DURABOLIN?
Summary for DURABOLIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 44 |
| Clinical Trials: | 2 |
| Patent Applications: | 5,159 |
| DailyMed Link: | DURABOLIN at DailyMed |
Recent Clinical Trials for DURABOLIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Morten Tange Kristensen PT, PhD | Phase 2 |
| University Hospital Ostrava | N/A |
US Patents and Regulatory Information for DURABOLIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Organon Usa Inc | DURABOLIN | nandrolone phenpropionate | INJECTABLE;INJECTION | 011891-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Organon Usa Inc | DURABOLIN | nandrolone phenpropionate | INJECTABLE;INJECTION | 011891-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
